- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Social Media
- Solebury Trout Talks
- Scoop: SR One crew completes a complicated spinout from GlaxoSmithKline. And now they have a $500M fund to invest on their own
- EndpointNews - The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
- COVID19 Resources - free to access
- LSP closes largest ever European life sciences fund at $600 million
- Highland Capital Management LP files for Chapter 11 bankruptcy -- Bloomberg
- Versant Ventures Enables Launch of Vensana Capital to Focus on Medtech Sector
- HBM Partners Biopharma M&A Update
- Barron: Ziad Bakri interview (T. Rowe Health Sciences Fund)
- WSJ - Beleaguered Money Managers Find Bright Spot in ESG
- WSJ - NYSE Cuts Fees to Court Biotech Listings Away From Nasdaq
- WSJ: SEC Moves to Ease Fraud Audits for Smaller Companies
- Life Sci VC - Why Reputation Is More Important Than Ever For Biotech Companies … And What You Can Do About It
- How can Donnelley Financial Solutions (DFIN) help Life Sciences companies accelerate their deal execution?
- CBS 60 Minutes - Could gene therapy cure sickle cell anemia?
- Barron's: Why Big Pharma Is Diving Into Gene Therapy
- The Wall Street Journal - A Big, Fatty Opportunity for Big Pharma
- Bloomberg - Biotech Stocks Are Enjoying Their Best-Ever Start to the Year
- Bloomberg - Citadel, Point72 Hammered by Monthly Losses in November Comedowb
- Bloomberg - Balyasny Cuts 125 People as Hedge Fund Bleeds Assets
- The drug pricing maze - Axios
- New York Aims to Jump-Start City's Drug Industry With Tower Pact
- Private equity giant Blackstone buys Clarus in biopharma push - Fierce biotech
- September 2018 Sell-Side Update
- Let’s Throw a Patent-Burning Party
- IRS considering revising rules requiring spin-offs generate revenue to qualify for tax-free status -- Bloomberg
- Biotech Success Stories: Achieving Value From Your Company - Trailblazer Webinar Series
- Trout Update on MiFiD II